Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis

Thorax

Volumn 61, Issue 1, 2006, Pages 80-85

  De Jong, P A ^a   Lindblad, A ^b   Rubin, L ^c   Hop, W C J ^d   De Jongste, J C ^a   Brink, M ^b   Tiddens, H A W M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^c Istituto di Radiologia   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIAGNOSTIC TEST; DISEASE COURSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG DISEASE; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SWEAT TEST;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 30844473744     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2005.045146     Document Type: Article

References (37)

1. Tiddens HA, Koopman LP, Lambert RK, et al. Cartilaginous airway wall dimensions and airway resistance in cystic fibrosis lungs. Eur Respir J 2000;15:735-42.
2. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
3. Tiddens H, Silverman M, Bush A. The role of inflammation in airway disease: remodeling. Am J Respir Crit Care Med 2000;162:S7-10.
4. Maffessanti M, Candusso M, Brizzi F, et al. Cystic fibrosis in children: HRCT findings and distribution of disease. J Thorac Imaging 1996;11:27-38.
5. de Jong PA, Ottink MD, Robben SG, et al. Pulmonary disease assessment in cystic fibrosis: comparison of CT scoring systems and value of bronchial and arterial dimension measurements. Radiology 2004;231:434-9.
6. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004;23:93-7.
7. Tiddens HA. Detecting early structural lung damage in cystic fibrosis. Pediatr Pulmonol 2002;34:228-31.
8. De Jong PA, Nakano Y, Hop WC, et al. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am J Respir Crit Care Med 2005;172:218-24.
9. Bhalla M, Turcios N, Aponte V, et al. Cystic fibrosis: scoring system with thinsection CT. Radiology 1991;179:783-8.
10. Brody AS, Molina PL, Klein JS, et al. High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 1999;29:731-5.
11. Helbich TH, Heinz-Peer G, Fleischmann D, et al. Evolution of CT findings in patients with cystic fibrosis. AJR Am J Roentgenol 1999;173:81-8.
12. Santamaria F, Grillo G, Guidi G, et al. Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 1998;101:908-13.
13. Brody AS, Klein JS, Molina PL, et al. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004;145:32-8.
14. Quanjer PH, Borsboom GJ, Brunekreff B, et al. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995;19:135-42.
15. Zapletal A, Samanek M, Paul T. Lung function in children and adolescents. Methods, reference values. Basel: Karger, 1987.
16. European Respiratory Society. Standardized lung function testing. Eur Respir J 1993;6(Suppl 16):5-40.
17. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
18. Young K, Aspestrand F, Kolbenstvedt A. High resolution CT and broncnography in the assessment of bronchiectasis. Acta Radiol 1991;32:439-41.
19. Silverman PM, Godwin JD. CT/bronchographic correlations in bronchiectasis. J Comput Assist Tomogr 1987;11:52-6.
20. Phillips MS, Williams MP, Flower CD. How useful is computed tomography in the diagnosis and assessment of bronchiectasis? Clin Radiol 1986;37:321-5.
21. Kang EY, Miller RR, Muller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 1995;195:649-54.
22. Gaillard EA, Carty H, Heaf D, et al. Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol 2003;47:215-20.
23. Eastham KM, Fall AJ, Mitchell L, et al. The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax 2004;59:324-7.
24. Martinez-Garcia MA, Perpina-Tordera M, Roman-Sanchez P, et al. Quality-of-life determinants in patients with clinically stable bronchiectasis. Chest 2005;128:739-45.
25. Robinson TE, Leung AN, Northway WH, et al. Spirometer-triggered high-resolution computed tomography and pulmonary function measurements during an acute exacerbation in patients with cystic fibrosis. J Pediatr 2001;138:553-9.
26. Shah RM, Sexauer W, Ostrum BJ, et al. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 1997;169:375-80.
27. Quan JM, Tiddens HA, Sy JP, et al. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities. J Pediatr 2001;139:813-20.
28. Fuchs HJ, Borowitz DS, Christiansen DH, et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med 1994;331:637-42.
29. Ramsey BW, Dorkin HL, Eisenberg JD, et al. Efficacy of aerosolized tobramycin in patients with cystic fibrosis. N Engl J Med 1993;328:1740-6.
30. Konstan MW, Byard PJ, Hoppel CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995;332:848-54.
31. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004;24:1071-2.
32. Rawlings D, Tennant D, Furness J. Progressive damage on high-resolution computed tomography. Eur Respir J 2004;24:1071.
33. de Jong PA, Golmohammadi K, Nakano Y, et al. Modelling the mortality risk associated with radiation exposure from cumulative computed tomography in cystic fibrosis. Am J Respir Crit Care Med 2005;171:A576.
34. Dorlochter L, Nes H, Fluge G, et al. High resolution CT in cystic fibrosis-the contribution of expiratory scans. Eur J Radiol 2003;47:193-8.
35. Goris ML, Zhu HJ, Blankenberg F, et al. An automated approach to quantitative air trapping measurements in mild cystic fibrosis. Chest 2003;123:1055-63.
36. Robinson TE, Leung AN, Northway WH, et al. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003;168:588-93.
37. Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003;22:972-9.